Bookmark Email Print page

Life Sciences & Health Care

Improving the quality of care

The Global Life Sciences and Health care practice was born out of our Firm’s recognition of the unique opportunity presented to us by the enormous amount of growth and changes in that market. This industry was specifically identified in our Firm’s strategic assessment as a top priority for our global organization’s future growth and success.

Combining our life sciences and health care practices into a single global industry group is a natural step that enables us to achieve significant synergies and more quickly increase our competitive resources and capabilities.

Today, health organizations must balance quality care and accountability in an environment of increased costs allied to limited resources and funding.

Deloitte works extensively with a range of health providers and their suppliers, both in the public and private sector. Together with our clients, we aim to improve the quality of care while creating and sustaining long-term, bottom-line success.

We are also fully cognizant of the growing market in health tourism and are equipped to advise our clients on the latest trends and market needs.

Deloitte offers comprehensive, customized solutions that will assist you:

  • Build and sustain financial strength
  • Implement best practices
  • Mitigate risk and manage compliance
  • Accelerate innovation and growth.

We offer a wide spectrum of professional services, backed by years of health care experience. We provide a broad range of advisory skills including “evidence based” decision support, process improvement and activity based management services, alongside our traditional strengths in auditing, accounting, tax and financial advisory services.

Featured list

  • Deloitte Middle East | 2011 Survey of the UAE healthcare sector
    As the government increasingly focuses its efforts on attracting more prestigious private healthcare providers, Deloitte Middle East’s newly released 2011 Survey of the UAE healthcare sector looks at the opportunities and challenges for private providers.
  • The pharmaceutical innovation dilemma
    Pharma innovation is facing a fundamental productivity challenge. Investment in R&D has outpaced sales growth, but this has not increased output of new medicines. Execs are seeking greater transparency in R&D decision making.
  • 'App' for better health
    Deloitte Australia helps Victorian Department of Health develop smartphone and tablet apps for Better Health Channel (BHC), one of Australia's leading health, medical and lifestyle information websites.
  • 2011 global survey of health care consumers
    Explore the findings from Deloitte's fourth consumer survey, based on the findings from 15,000 consumers in 12 countries. See how economic uncertainty and skyrocketing costs are effecting consumer behavior.

Learn more

  • Aftermath of the global recession
    How did the economic crisis affect life sciences business priorities and strategies?
  • The future of the life sciences industries: Transformation amid rising risk
    As life sciences companies face many challenges, survey results show how the industry is transforming during a period of increased risk.
  • Provider Agility in the Face of Health Reform
    The impacts and implications of reform for provider organizations

Stay connected

  • Contact us
  • Careers
  • Submit RFP
  • Like us on Facebook
  • Follow us on Twitter
  • Join us on LinkedIn
  • Watch us on YouTube